2026
Epcoritamab Monotherapy as Outpatient Treatment for Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Interim Results From EPCORE NHL-6., David Andorsky, Adelba Torres Lopez, Rakhee Vaidya, Fernando Vargas Madueno, Sami Ibrahimi, Seema Naik, Mitul Gandhi, Julie Erika Haydu, Bradley Lash MD, Mark Fesler, John Hrom, Eric H Lee, Suchitra Sundaram, Kristin Conte, Kojo Osei-Bonsu, Thomas Doerr, Yang Bai, Neha Dixit, Christian W Eskelund, Alexander P Boardman, Ralph Boccia, Christina Y Lee, and Jeff P Sharman (Article)
A Phase 2, Open-Label, Multicenter Study of the Safety and Efficacy of TAK-007 in Adult Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma., Justin M Darrah; Indumathy Varadarajan; Amitkumar Mehta; Jennifer N Saultz; Matthew S McKinney; Monalisa Ghosh; Usama Gergis MD, MBA; Andrew Krueger; Kevin J Galinsky; Girish Bende; Ajeetha Ramachandran; Varsha Sundaresan; Siddha Kasar; Bradley Hupf; Sharon Chen; Leopold Sellner; and Reem Karmali (Article)
Closing Remarks/Key Takeaways, Ranju Gupta MD and Deborah W Sundlof DO (Presentation)
Management of Cardio-Oncology Emergencies, Ranju Gupta MD, Deborah W Sundlof DO, and Robert A. Watson (Presentation)
Modern Immunotherapy Landscape: IO, BiTEs, CAR-T and Practical Toxicity Pearls: Solid Tumor, Maged Khalil MD (Presentation)
A-625 - SUPRAME: A Phase 3 trial evaluating anzutresgene autoleucel (anzu-cel, IMA203) PRAME-directed T-cell receptor T-cell therapy vs investigator’s choice in previously treated advanced cutaneous melanoma, Suresh G. Nair MD (Article)
Melanoma Update: TIL/IL-2 and Beyond, Suresh G. Nair MD (Presentation)
Atezolizumab plus FOLFOX for Stage III Mismatch Repair-Deficient Colon Cancer., Frank A Sinicrope, Fang-Shu Ou, Dirk Arnold, Walter R Peters, Robert J Behrens, Christopher H Lieu, Khalid Matin, Deirdre J Cohen, Samara L Potter, Andrew B Nixon, Lisa A Kottschade, Emily Kathol, Wendy L Frankel, Ardaman Shergill, Dennis Hsu, Anke Reinacher-Schick, Paul Mehan, Philip J Gold, Maged Khalil MD, Tyler Zemla, Clare Gatten, Eileen M O'Reilly, and Jeffrey A Meyerhardt (Article)
YIA26-003: Characterizing the Peripheral T-Cell Repertoire in Patients With Unresectable Melanoma Treated With the IDO- and PD-L1 Targeted Peptide Vaccine IO102-IO103 and Nivolumab-Relatlimab Fixed-Dose Combination., James W Smithy, Victoria Ciallella, Claire Thant, Hannah L Kalvin, Jaykumar Thumar, Suresh G. Nair MD, Alexander Noor Shoushtari, Parisa Momtaz, Monica F Chen, Katherine S Panageas, Benjamin D Greenbaum, Neeman Mohibullah, and Michael A Postow (Article)
YIA26-003: Characterizing the Peripheral T-Cell Repertoire in Patients With Unresectable Melanoma Treated With the IDO- and PD-L1 Targeted Peptide Vaccine IO102-IO103 and Nivolumab-Relatlimab Fixed-Dose Combination., James W Smithy, Victoria Ciallella, Claire Thant, Hannah L Kalvin, Jaykumar Thumar, Suresh G. Nair MD, Alexander Noor Shoushtari, Parisa Momtaz, Monica F Chen, Katherine S Panageas, Benjamin D Greenbaum, Neeman Mohibullah, and Michael A Postow (Article)
Short- and Long-term Metabolic Exposure Data as Predicators of Coronary Microvascular Dysfunction in a Positron Emission Tomography Myocardial Perfusion Imaging (PET-MPI) Cohort with Near Concurrent Angiography., Joseph Van Galen, Sarah J Ratcliffe, and Jamieson Bourque (Article)
Measurable residual disease testing in acute myeloid leukemia: current state, foundational models, and tools for future development., Joseph Van Galen, Stephen D Willis, Ashish Bains, and Sara H Small (Article)
2025
Efficacy of Total-Body Irradiation-based Intensified Myeloablative Regimens for Acute Leukemia-An International Collaborative Study., Yasuyuki Arai; Ruta Brazauskas; Naya He; A Samer Al-Homsi; Saurabh Chhabra; Minoo Battiwalla; Masamitsu Yanada; Amir Steinberg; Miguel Angel Diaz Perez; Sanghee Hong; Junya Kanda; Asad Bashey; Haydar A Frangoul; Sherif M Badawy; Leo F Verdonck; Hillard M Lazarus; Jean A Yared; Hasan Hashem; Akshay Sharma; Mahmoud Aljurf; Ajoy L Dias; Muhammad Bilal Abid; Baldeep Wirk; César O Freytes; Amer M Zeidan; Usama Gergis MD, MBA; Amer Beitinjaneh; Medhat Askar; Jeffrey J Pu; Leslie E Lehmann; Hemalatha G Rangarajan; William A Wood; Shahrukh Hashmi; Shingo Yano; Shinichi Kako; Yukiyasu Ozawa; Noriko Doki; Yoshinobu Kanda; Takahiro Fukuda; Yuta Katayama; Tatsuo Ichinohe; Junji Tanaka; Takanori Teshima; Shinichiro Okamoto; Yoshiko Atsuta; and Wael Saber (Article)
A phase 1b/2 study of intermittent talazoparib plus temozolomide in patients with metastatic castration-resistant prostate cancer and no mutations in DNA damage response genes., Karen A Autio, Christos E Kyriakopoulos, Paul Palyca MD, Han Xiao, Hamid Emamekhoo, Daniel Danila, Mehrin Jan, Victoria Catharine, Elyn Riedel, Michael Devitt, A Douglas Laird, and Howard I Scher (Article)
A Training Toolkit for Introducing Stem Cell Transplantation to the Inpatient Oncology Nurse, Susan G. Berg BSN, RN, CMSRN, OCN; Jenna Ruggiero BSN, RN; Jordan Mellinger Kish MSN, RN; Lisa Russo MSN, RN; Gavin Bauer BSN, RN; and Tammy Selby RN (Poster)
Assessing interest and satisfaction with integrative oncology approaches among hospitalized patients, Xia Bi MD, MS and Usama Gergis MD, MBA (Article)
Firicabtagene autoleucel (firi-cel), a CD22-directed CAR T-cell therapy, for patients with relapsed/refractory large B-cell lymphoma: Results from the phase 2 study (FIRCE-1 Trial), Usama Gergis MD, MBA (Article)
Outcomes of myeloablative vs reduced and non-myeloablative conditioning in MRD-negative AML and ALL with ptcy-based GVHD prophylaxis, Usama Gergis MD, MBA (Article)
Concordance of Management of Early and Locally Advanced Esophageal and Esophagogastric Junction Tumors with National Comprehensive Cancer Network Guidelines, Kanchan Gupta; Melissa Kratz RN, MSN, AOCN; Sean Quinlan-Davidson MD; and Savitri Skandan MD (Poster)
Impact of Adopting a Multidisciplinary Care Delivery Model on Treatment Effectiveness and Outcomes in Stage III Melanoma Patients at a Community-Based Academic Institution: A Retrospective Study., Zeeshan Hafeez MD; Aidan Johnson; Nicole Nester DO; Hariharasudan Mani MD; Aaron U. Blackham; Alyson McIntosh MD; Lauren Davis PA-C, MSPAS; Angela Miller RN; Alexandra Bauman; Morgan M. Horton BSN, RN, CCRC; and Suresh G. Nair MD (Article)
Prelude to the perfect storm: the many triggers of secondary hemophagocytic lymphohistiocytosis., Jordan B. Hatch DO, Elizabeth M Rich, Michael W Rich, Minh N Tran, and Daniel Wood (Article)
A retrospective analysis of the association of obesity with anthracycline- and trastuzumab-induced cardiotoxicity in the treatment of breast cancer and lymphoma., Mallorie L. Huff; Ranju Gupta MD; Rahul Gupta MD; Kelly C. Schadler MSN, CRNP; Shae Duka MPH; Vienna Histon-Figliolini; Joshua A. Kalter; Amogh M. Joshi DO; Nadeem V. Ahmad MD; Wilbert S Aronow; and Deborah W Sundlof DO (Article)
Neoadjuvant Chemotherapy for High-risk Localized Upper Tract Urothelial Carcinoma: Final Long-term Outcomes from a Phase 2 Clinical Trial and an Expanded Cohort., Viranda H Jayalath, Melissa Assel, Gopa Iyer, Scot Niglio, Bernard H Bochner, Guido Dalbagni, S Machele Donat, Harry W Herr, Eugene K Cha, Timothy F Donahue, Eugene J Pietzak, A Ari Hakimi, Kwanghee Kim, Hikmat A Al-Ahmadie, H Alberto Vargas, Soleen Ghafoor, Nicole E Benfante, Daniel V Rodriguez, Abraham R Meyerson, Anoop M Meraney, Steven J Shichman, Jeffrey M Kamradt, Suresh G. Nair MD, Angelo A. Baccala MD, Paul Palyca MD, Bradley Lash, Muhammad A. Rizvi MD, Scott K Swanson, Antonio F Muina, Andrea B Apolo, Jonathan E Rosenberg, Dean F Bajorin, and Jonathan A Coleman (Article)
Multicenter basket trial for Central Nervous System tumors identifies activity of the CDK4/6 inhibitor abemaciclib in recurrent meningioma., Thomas J Kaley, Christian Grommes, Elizabeth Coffee, Robert J Young, Tara Morrison MD, Ahmad Daher, Lauren R Schaff, Yufei Deng, Subhiksha Nandakumar, Eli L Diamond, Lisa M DeAngelis, Katherine S Panageas, Igor Gavrilovic, Andrew Lin, Elena Pentsova, Jacqueline Stone, Bianca D Santomasso, Anna F Piotrowski, Suresh G. Nair MD, Nikolaus Schultz, Anne S Reiner, and Ingo K Mellinghoff (Article)
Doc why am I so tired? Iron deficiency in the OB/GYN practice, Bradley Lash (Presentation)
Outpatient administration of epcoritamab monotherapy for relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL): Results from EPCORE NHL-6 by race and ethnicity, Bradley Lash MD (Article)
Sotorasib provides a durable response in high-grade metastatic ovarian serous adenocarcinoma harbouring KRAS G12C mutation., Hariharasudan Mani MD and Suresh G. Nair MD (Article)
Retrospective study of unresectable stage III or stage IV melanoma refractory to immune checkpoint and BRAF/MEK inhibitors, treated with triplet vs doublet therapy: A single institution experience, Hariharasudan Mani MD; Nicole Nester DO; Grace Rauscher; Timothy Johnson MD; Zeeshan Hafeez MD; Darshan Lal MD; Colby L. Presley; Hope Kincaid MPH, CPH; Alyson McIntosh MD; Aaron U. Blackham MD; and Suresh G. Nair MD (Article)
Interprovider Variation in Initiation of Bone-Modifying Agents for Patients With Prostate Cancer., Aaron P Mitchell, Andrew Salner, Paul Palyca MD, Azeez Farooki, Sonia Persaud, Nirjhar Chakraborty, Dedipya Bhamidipati, Maria Klimchuk, Michaela A Dinan, Michael S Leapman, Allison Lipitz-Snyderman, Anis Hamid, Jamie S Ostroff, and Michael J Morris (Article)
Chimeric Antigen Receptor T-cell Therapy for Richter Transformation: A CIBMTR analysis., Kalyan V Nadiminti; Kwang W Ahn; Jinalben Patel; Qinghua Lian; Evandro Bezerra; Andy Chen; Siddhartha Ganguly; Usama Gergis MD, MBA; Hamza Hashmi; Mohamed A Kharfan-Dabaja; John Kuruvilla; Lazaros Lekakis; Frederick L Locke; Hemant Murthy; Muhamad Alhaj Mousthafa; Miguel-Angel Perales; Priyanka Pophali; Peter A Riedell; Nirav N Shah; Trent Wang; Marcelo Pasquini; Mehdi Hamadani; Cameron J Turtle; Alex F Herrera; and Mazyar Shadman (Article)
Author Correction: Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial., Farshad Nassiri, Vikas Patil, Leeor S Yefet, Olivia Singh, Jeff Liu, Rachel M A Dang, Takafumi N Yamaguchi, Mariza Daras, Timothy F Cloughesy, Howard Colman, Priya U Kumthekar, Clark C Chen, Robert Aiken, Morris D Groves, Shirley S Ong, Rohan Ramakrishna, Michael A Vogelbaum, Simon Khagi, Thomas Kaley, Jason M Melear, David M Peereboom, Analiz Rodriguez, Maxim Yankelevich, Suresh G. Nair MD, Vinay K Puduvalli, Kenneth Aldape, Andrew Gao, Álvaro López-Janeiro, Carlos E de Andrea, Marta M Alonso, Paul Boutros, Joan Robbins, Warren P Mason, Adam M Sonabend, Roger Stupp, Juan Fueyo, Candelaria Gomez-Manzano, Frederick F Lang, and Gelareh Zadeh (Article)
Variation in guideline-concordant use of bone modifying agents for prostate cancer, Paul Palyca MD (Article)
Concurrent Inhibition of the RAS-MAPK Pathway and PIKfyve Is a Therapeutic Strategy for Pancreatic Cancer, Usman Shah MD and Sam Skariah MD (Article)
Benchmarking clinical reasoning and accuracy of large language models on breast oncology multiple-choice questions, Ritu Sidgal and Trevor Lin (Article)
Solid Organ Malignancies: Management of the Cancer patient with Chest Pain, Shortness of Breath, and QTc Prolongation, Savitri Skandan MD and Nadeem V. Ahmad MD (Presentation)
Understanding Telomere Biology in Hematopoietic Cell Transplantation: A Dynamical Systems Perspective., Amir Toor MD, Morgan Horton, Haniya Khalid, Elizabeth Krieger, Tsung-Po Lai, Stephen R Spellman, John E Levine, Wael Saber, Abraham Aviv, Valerie Stewart, and Shahinaz M Gadalla (Article)
Understanding Telomere Biology in Hematopoietic Cell Transplantation: A Dynamical Systems Perspective., Amir Toor MD; Morgan M. Horton BSN, RN, CCRC; Haniya Khalid; Elizabeth Krieger; Tsung-Po Lai; Stephen R Spellman; John E Levine; Wael Saber; Valerie Stewart; and Shahinaz M Gadalla (Article)
Interim analysis of LimiTec, a prospective trial of limited-duration teclistamab for relapsed/refractory multiple myeloma, Zachary Wolfe MD (Article)
Infection after CD19 chimeric antigen receptor T cell therapy for large B cell lymphoma: Real-world analysis from CIBMTR., Kitsada Wudhikarn; Megan M Herr; Min Chen; Michael J Martens; John H Baird; Lohith Gowda; Hemalatha G Rangarajan; Muhammad Bilal Abid; Mohamed A Kharfan-Dabaja; Kristen M Williams; Siddhartha Ganguly; Jo-Anne H Young; Akshay Sharma; Giancarlo Fatobene; Tania Jain; Christopher G Kanakry; Dipenkumar Modi; Natalie S Grover; Baheyeldin Salem; Marjorie Vieira Batista; Paschalis Vergidis; Dwight E Yin; Amer M Beitinjaneh; Amar H Kelkar; Taiga Nishihori; Jennifer Holter-Chakrabarty; Usama Gergis MD, MBA; Melody Smith; Zeinab El Boghdadly; Christopher E Dandoy; Hemant S Murthy; Anna R Huppler; Miguel-Angel Perales; Roy F Chemaly; Joshua A Hill; Marcie Riches; and Jeff J Auletta (Article)
2024
Improving the understanding of integrative oncology approaches among hospitalized patients with cancer, Xia Bi MD, MS and Usama Gergis MD, MBA (Article)
Outcome of Multiple Myeloma Patients Undergoing Allogeneic Stem Cell Transplant with Post-Transplant Cyclophosphamide – a Single Center Experience, Xia Bi MD, MS and Usama Gergis MD, MBA (Article)
Nivolumab plus relatlimab and nivolumab plus ipilimumab for patients with advanced renal cell carcinoma: results from the open-label, randomised, phase II FRACTION-RCC trial., T K Choueiri, T M Kuzel, S S Tykodi, E Verzoni, H Kluger, Suresh G. Nair MD, R Perets, S George, H Gurney, R K Pachynski, E Folefac, V Castonguay, C-H Lee, U Vaishampayan, W H Miller, P Bhagavatheeswaran, Y Wang, S Gupta, H DeSilva, C-W Lee, B Escudier, and R J Motzer (Article)
A Case of μ Heavy and λ Light Chain Amyloidosis in a Patient With Bi-Clonal (IgM κ and λ) Gammopathy Treated With Daratumumab., Armaan Dhaliwal MD, Ashish Tripathi, and Soumiya Ravi (Article)
Cabozantinib tolerability in metastatic renal cell carcinoma: A meta-analysis, Hafsa Farooq MD (Article)
Idecabtagene Vicleucel (ide-cel) Versus Standard Regimens (SRs) in Triple-Class–Exposed (TCE) Relapsed and Refractory Multiple Myeloma (RRMM): KarMMa-3 Subanalysis of Black Patients (pts), Usama Gergis MD, MBA (Article)
SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A prospective, multicenter, observational study., Joshua A Hill, Michael J Martens, Jo-Anne H Young, Kavita Bhavsar, Jianqun Kou, Min Chen, Lik Wee Lee, Aliyah Baluch, Madhav V Dhodapkar, Ryotaro Nakamura, Kristin Peyton, Dianna S Howard, Uroosa Ibrahim, Zainab Shahid, Paul Armistead, Peter Westervelt, John McCarty, Joseph McGuirk, Mehdi Hamadani, Susan DeWolf, Kinga Hosszu, Elad Sharon, Ashley Spahn, Amir Toor MD, Stephanie Waldvogel, Lee M Greenberger, Jeffery J Auletta, Mary M Horowitz, Marcie L Riches, and Miguel-Angel Perales (Article)
Rituximab-Associated Liver Toxicity Without Known Viral Reactivation., Taha Huda; Fawaz Hussain; Hariharasudan Mani MD; Shereen M F Gheith MD, PhD; and Savitri Skandan MD (Article)
Evaluation of Patients Admitted to the Hospital with Sepsis, Febrile Neutropenia, or Pneumonia Following Administration of Chemotherapy, Abigail Kennedy; Savitri Skandan MD; Dennis Sopka MD; and Melissa Kratz RN, MSN, AOCN (Poster)
Process Improvements for the Treatment of Iron Deficiency Anemia in Pregnancy, Iris Kong MD, Natalie Chlus MD, and Bradley Lash MD (Poster)
Subcutaneous epcoritamab (SC epcor) administered outpatient (outpt) for relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL): Results from phase 2 EPCORE NHL-6, Bradley Lash (Article)
A Rare Case of Duodenal Adenocarcinoma With Brain Metastasis., Hariharasudan Mani MD, Alisha Hossain DO, Elsie S. Lee MD, and Muhammad A. Rizvi MD (Article)
Retrospective Study of Unresectable Stage III or Stage IV Melanoma Patients Refractory to Immune Check Point and BRAF/MEK Inhibitors, Treated with Triplet Therapy: A Single Institution Experience., Hariharasudan Mani MD; Suresh G. Nair MD; Timothy Johnson MD; Darshan Lal MD; Zeeshan Hafeez MD; Hope Kincaid MPH, CPH; Alyson McIntosh MD; and Aaron U. Blackham MD (Presentation)
5-FU Mediated Coronary Vasospasm Leading to Stress Cardiomyopathy, Merissa Misiura MD, Amogh M. Joshi DO, Noah Dessalegn MD, Muhammad Aamir MD, Nicholas Lamparella DO, and Ronak Patel MD (Poster)
Adjuvant Nivolumab for Localized Renal Cell Carcinoma at High Risk of Recurrence After Nephrectomy: Part B of the Randomized, Placebo-Controlled, Phase III CheckMate 914 Trial., Robert J Motzer, Axel Bex, Paul Russo, Yoshihiko Tomita, Hernan Javier Cutuli, Carlos Rojas, Marine Gross-Goupil, Giovanni Schinzari, Bohuslav Melichar, Philippe Barthélémy, Abraham Ruiz Garcia, Jeffrey Sosman, Marc-Oliver Grimm, Jeffrey C Goh, Cristina Suarez, Christian K Kollmannsberger, Suresh G. Nair MD, Brian M Shuch, Jian Huang, Burcin Simsek, Julia Spiridigliozzi, Chung-Wei Lee, Maximiliano van Kooten Losio, and Viktor Grünwald (Article)
A phase 2 trial of IO102-IO103 and nivolumab-relatlimab fixed-dose combination in previously untreated, unresectable melanoma, Suresh G. Nair MD (Article)
Evaluating Lehigh Valley Health Network's Stage 1A Lung Cancer Care in Concordance with National Guidelines, Katie O'Connor; Melissa Kratz RN, MSN, AOCN; Savitri Skandan MD; and Dennis Sopka MD (Poster)
S3256 A Rare Case of Primary Germinoma of the Spinal Cord Causing Progressive Dysphagia, Rachel Patel DO, Amanda Jacubowsky DO, Nicholas Lamparella DO, and Paul Palyca MD (Article)
An epidemiologic study comparing cancer- and noncancer-associated venous thromboembolism in a racially diverse Southeastern United States county., Andrew M Peseski, Sargam Kapoor, Maragatha Kuchibhatla, Alys Adamski, Karon Abe, Michele G Beckman, Nimia L Reyes, Lisa C Richardson, Ibrahim Saber, Ryan Schulteis, Bhavana Pendurthi Singh MD, Andrea Sitlinger, Elizabeth H Thames, and Thomas L Ortel (Article)
Intravascular large B-cell lymphoma masquerading as stroke successfully treated with R-Hyper-CVAD., Christopher Popiolek, Kanchan Gupta, Mallorie L. Huff, and Ranju Gupta MD (Article)
Osimertinib-Induced Myositis in a Patient With Metastatic Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutation., Aatma Ram MD, Chun Siu, Abir Mukherjee MD, and Ranju Gupta MD (Article)
A Multi-Institution Phase 2, Single-Arm, Non-Inferiority Study of Limited-Duration Teclistamab for Relapsed and Refractory Multiple Myeloma (LimiTec), B Razzi, S Girgis, L Finnaca, S Le, S Whittington, G Mellgard, C B. Grady, Zachary Wolfe MD, A F. Binder, R Chakraborty, C Strouse, H Shaikh, S Kapur, S Susanibar-Adaniya, A Waxman, D T. Vogl, A D. Cohen, E A. Stadtmauer, W-T Hwang, and A L. Garfall (Article)
Early on-treatment assessment of T-cells, cytokines and tumor DNA with adaptively-dosed nivolumab + ipilimumab: final results from the phase 2 ADAPT-IT study., James W Smithy, Hannah L Kalvin, Fiona D Ehrich, Ronak Shah, Matthew Adamow, Vladislav Raber, Colleen A Maher, Jenna Kleman, Debra A G McIntyre, Alexander N Shoushtari, Allison Betof Warner, Margaret K Callahan, Parisa Momtaz, Omar Eton, Suresh G. Nair MD, Jedd D Wolchok, Paul B Chapman, Michael F Berger, Katherine S Panageas, and Michael A Postow (Article)
Sars-Cov-2 Vaccination in the First Year after Hematopoietic Cell Transplant or Chimeric Antigen Receptor T Cell Therapy: A CIBMTR and BMT CTN Study, Amir Toor MD (Article)
Ambulatory teclistamab administration in patients with relapsed/refractory multiple myeloma, Amber Zukas CRNP (Article)
TAKING A BITE OUT OF HOSPITAL ADMISSION DAYS USING A TEAM APPROACH TO MANAGING PATIENTS AT RISK FOR TREATMENT RELATED TOXICITIES, Amber Zukas CRNP (Article)
2023
Open label single arm study to assess the implementation of home based daratumumab administration in patients being treated for multiple myeloma., Xia Bi MD, MS and Usama Gergis MD, MBA (Article)
Outcome of Multiple Myeloma Patients Undergoing Allogeneic Stem Cell Transplant with Post-Transplant Cyclophosphamide - a Single Center Experience, Xia Bi MD, MS and Usama Gergis MD, MBA (Article)
Validation of Immunotherapy Response Score as Predictive of Pan-solid Tumor Anti-PD-1/PD-L1 Benefit., Benjamin J Bulen, Nickolay A Khazanov, Daniel H Hovelson, Laura E Lamb, Marc Matrana, Mark E Burkard, Eddy Shih-Hsin Yang, William J Edenfield, Elizabeth Claire Dees, Adedayo A Onitilo, Gary L Buchschacher, Alan M Miller, Benjamin M Parsons, Timothy R Wassenaar, Jennifer M Suga, Robert D Siegel, William Irvin, Suresh G. Nair MD, Jennifer N Slim, Jamal Misleh, Jamil Khatri, Gregory A Masters, Sachdev Thomas, Malek M Safa, Daniel M Anderson, Jonathan Mowers, Anna C Dusenbery, Stephanie Drewery, Komal Plouffe, Travis Reeder, Hana Vakil, Lynnae Patrias, Amanda Falzetta, Ryan Hamilton, Kat Kwiatkowski, D Bryan Johnson, Daniel R Rhodes, and Scott A Tomlins (Article)
Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma., Jonathan A Coleman, Wesley Yip, Nathan C Wong, Daniel D Sjoberg, Bernard H Bochner, Guido Dalbagni, S Machele Donat, Harry W Herr, Eugene K Cha, Timothy F Donahue, Eugene J Pietzak, A Ari Hakimi, Kwanghee Kim, Hikmat A Al-Ahmadie, H Alberto Vargas, Ricardo G Alvim, Soleen Ghafoor, Nicole E Benfante, Anoop M Meraney, Steven J Shichman, Jeffrey M Kamradt, Suresh G. Nair MD, Angelo A. Baccala MD, Paul Palyca MD, Bradley Lash MD, Muhammad A. Rizvi MD, Scott K Swanson, Antonio F Muina, Andrea B Apolo, Gopa Iyer, Jonathan E Rosenberg, Min Y Teo, and Dean F Bajorin (Article)
Comparison of outcomes of Clostridium difficile infection in autologous stem cell transplant recipients compared to allogenic stem cell transplant recipients., Armaan Dhaliwal MD (Article)
Effect on hospital outcomes of hematopoietic stem cell transplant recipients with Clostridium difficile infection., Armaan Dhaliwal MD (Article)
Effect on in-hospital outcomes of patients with hepatocellular carcinoma on aspirin., Armaan Dhaliwal MD (Article)
Genomic profiling between Hispanic Americans (HA) and non-Hispanic (NHW) with advanced prostate cancer: A retrospective analysis of tissue, liquid, and germline testing., Armaan Dhaliwal MD (Article)
Health disparities in metastatic hormone-sensitive prostate cancer (mHSPC) presentations and outcomes among Hispanic Americans (HA) versus non-Hispanic Whites (NHW)., Armaan Dhaliwal MD (Article)
Engraftment syndrome after allogeneic stem cell transplantation: a systematic review and meta-analysis., Ghada ElGohary; Amir Toor MD; and Usama Gergis MD, MBA (Article)
EP04.02-04 Screening Success: A Review of Outcomes from Lehigh Valley Health Network’s Multi-Disciplinary Lung Cancer Screening Program, Eliot L. Friedman MD, Timothy Johnson MD, Andrea Dally CRNP, Kenneth Cavorsi MD, Richard S. Chang MD, Dennis Sopka MD, C. Gerard Petersen MD, Frank Sperrazza DO, and Dylan Soller DO (Article)
273 - Outcomes for Anti-CD19+ Chimeric Antigen Receptor T (CAR-T) Cell Therapy for Non Hodgkin Lymphoma (NHL) across a Large Community Transplant and Cellular Therapy Network, Usama Gergis MD, MBA (Article)
Early results from a phase 1, multicenter trial of PSCA-specific GoCAR T cells (BPX-601) in patients with metastatic castration-resistant prostate cancer (mCRPC)., Usama Gergis MD, MBA (Article)
Phase 1 trial of LYL797, a ROR1-targeted CAR T-cell therapy enhanced with genetic and epigenetic reprogramming, in advanced triple-negative breast cancer (TNBC) and non-small cell lung cancer (NSCLC), Usama Gergis MD, MBA (Article)
High dose valacyclovir for cytomegalovirus prophylaxis following allogeneic hematopoietic cell transplantation., Kelly G Hawks, Amanda Fegley, Roy T Sabo, Catherine H Roberts, and Amir Toor MD (Article)
SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study., Joshua A Hill, Michael J Martens, Jo-Anne H Young, Kavita Bhavsar, Jianqun Kou, Min Chen, Lik Wee Lee, Aliyah Baluch, Madhav V Dhodapkar, Ryotaro Nakamura, Kristin Peyton, Zainab Shahid, Paul Armistead, Peter Westervelt, John McCarty, Joseph McGuirk, Mehdi Hamadani, Susan DeWolf, Kinga Hosszu, Elad Sharon, Ashley Spahn, Amir Toor MD, Stephanie Waldvogel, Lee M Greenberger, Jeffery J Auletta, Mary M Horowitz, Marcie L Riches, and Miguel-Angel Perales (Article)
Plasmacytic neoplasm in a patient with chronic Immunosuppression: an unusual clinical presentation as shoulder mass, Alisha Hossain DO, Emily C. Skutnik DO, Rayna Abraham, Robert V. Decker MD, Mini G. Abraham MD, and Eliot L. Friedman MD (Poster)
Analysis of Systems of Care and Outcomes for Stage III Melanoma Patients at Lehigh Valley Topper Cancer Institute (2014-2019), Aidan Johnson and Suresh G. Nair MD (Poster)
Improved Overall Well-Being After Breast Conserving Therapy Using Three-Dimensional Bioabsorbable Markers and Tissue Rearrangement, a Single Institution's Preliminary Experience., Rebecca M Jordan, Monica Rebielak, Kelly Johnson, Marcus Fluck, and Jacqueline Oxenberg DO (Article)
207P Palbociclib (P) in patients (pts) with solid tumors with CDK4 or CDK6 amplification (amp): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study, Maged Khalil MD, M Rothe, P K. Mangat, E Garrett- Mayer, K F. Mileham, E R. Ahn, H L. Duvivier, L C. Farrington, M Akce, D Behl, P J. Gold, V K. Chiu, N Vijayvergia, C Calfa, A Gaba, F Meric-Bernstam, S M. Schetze, A Gregory, S Halabi, and R L. Schilsky (Article)
Immunotherapy May Improve Tumor Sensitivity to Palliative Chemotherapy in Platinum Resistant Ovarian Cancer., Rachel Kinney DO, Suresh G. Nair MD, Christine H. Kim MD, M Bijoy Thomas MD, and Martin DelaTorre DO (Article)
Brain Metastases With Malignant Peritoneal Mesothelioma: Never Reported Before., Darshan Lal MD, Merissa Misiura MD, Waqas Adeel, and Rizwan Tariq MD (Article)
The Correlation of Thyroid Hormone Levels and Anti-Thyroidal Drugs on Thyroid Size, Weight, and Ease of Surgical Dissection for Thyroidectomy for Graves' Disease., Kelcie Lushefski MD, Mary Wolf, James Dove, Marcus Fluck, and Jacqueline Oxenberg DO (Article)
Genetic Referrals, Appointments and Testing for BRCA Mutation in Ovarian Cancer Patients from 2019 to 2022, Julia Mandarino; Melissa Kratz RN, MSN, AOCN; Samantha Carr MS, LGCG; Savitri Skandan MD; and Christine H. Kim MD (Poster)
Kikuchi-Fujimoto Disease, Muhammad Masab, Natalya Surmachevska, and Hafsa Farooq MD (Book Chapter)
Physician knowledge, practice patterns, and barriers encountered regarding guideline-concordant use of bone modifying agents for prostate cancer., Aaron P Mitchell, Sonia Persaud, Paul Palyca MD, Andrew Salner, Azeez Farooki, Jamie S Ostroff, Michael J Morris, and Susan Chimonas (Article)
Barriers to guideline-concordant use of bone modifying agents for prostate cancer., A P. Mitchell, S Persaud, S Chimonas, A Salner, Paul Palyca MD, A Farooki, J Ostroff, and M J. Morris (Article)
Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial., Farshad Nassiri, Vikas Patil, Leeor S Yefet, Olivia Singh, Jeff Liu, Rachel M A Dang, Takafumi N Yamaguchi, Mariza Daras, Timothy F Cloughesy, Howard Colman, Priya U Kumthekar, Clark C Chen, Robert Aiken, Morris D Groves, Shirley S Ong, Rohan Ramakrishna, Michael A Vogelbaum, Simon Khagi, Thomas Kaley, Jason M Melear, David M Peereboom, Analiz Rodriguez, Maxim Yankelevich, Suresh G. Nair MD, Vinay K Puduvalli, Kenneth Aldape, Andrew Gao, Álvaro López-Janeiro, Carlos E de Andrea, Marta M Alonso, Paul Boutros, Joan Robbins, Warren P Mason, Adam M Sonabend, Roger Stupp, Juan Fueyo, Candelaria Gomez-Manzano, Frederick F Lang, and Gelareh Zadeh (Article)
Randomized, phase II, placebo-controlled trial of nintedanib for the treatment of radiation pneumonitis., Andreas Rimner, Zachary R Moore, Stephanie Lobaugh, Alexander Geyer, Daphna Y Gelblum, Raja-Elie E Abdulnour, Annemarie F Shepherd, Narek Shaverdian, Abraham J Wu, John Cuaron, Jamie E Chaft, Marjorie G Zauderer, Juliana Eng, Gregory J Riely, Charles M Rudin, Nicholas Vander Els, Mohit Chawla, Megan McCune, Henry Li, David R Jones, Dennis Sopka MD, Charles B Simone, Raymond Mak, Gerald L Weinhouse, Zhongxing Liao, Daniel R Gomez, Zhigang Zhang, and Paul K Paik (Article)
The Efficacy of Axillary Reverse Mapping for the Prevention of Lymphedema., Amanda E Ruffino, Joshua D Madera, Makayla M Dearborn, Katie Frank, and Jacqueline Oxenberg DO (Article)
TUMOR LYSIS SYNDROME IN PATIENT WITH HEPATOCELLULAR CARCINOMA AFTER CHEMOEMBOLIZATION, Chun Siu, Darshan Lal MD, and Muhammad A. Rizvi MD (Article)
Development and validation of an integrative pan-solid tumor predictor of PD-1/PD-L1 blockade benefit., Scott A Tomlins, Nickolay A Khazanov, Benjamin J Bulen, Daniel H Hovelson, Melissa J Shreve, Laura E Lamb, Marc R Matrana, Mark E Burkard, Eddy Shih-Hsin Yang, William Jeffery Edenfield, E Claire Dees, Adedayo A Onitilo, Michael Thompson, Gary L Buchschacher, Alan M Miller, Alexander Menter, Benjamin Parsons, Timothy Wassenaar, Leon C Hwang, J Marie Suga, Robert Siegel, William Irvin, Suresh G. Nair MD, Jennifer N Slim, Jamal Misleh, Jamil Khatri, Gregory Masters, Sachdev Thomas, Malek Safa, Daniel M Anderson, Kat Kwiatkowski, Khalis Mitchell, Tina Hu-Seliger, Stephanie Drewery, Andrew Fischer, Komal Plouffe, Eric Czuprenski, Jennifer Hipp, Travis Reeder, Hana Vakil, D Bryan Johnson, and Daniel R Rhodes (Article)
258 - Utilizing Biomarkers, CRP and Ferritin, to Predict the Development of Cytokine Release Syndrome in Patients Receiving Chimeric Antigen Receptor Cell Therapy, Amir Toor MD (Article)
413 - To CD16 or Not to CD16: Phenotypic Analysis of NK Cell Reconstitution after Myeloablative HLA Matched Unrelated HCT By CD16 Subpopulations, Amir Toor MD (Article)
8 - Increased Donor Inhibitory KIR Improve Survival Following HLA Matched Unrelated Donor HCT in Pediatric Acute Leukemia: Subgroup Analysis, Amir Toor MD (Article)